Home
/
Solid Biosciences Inc.
/
Financials
/
Quarterly
Solid Biosciences Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Solid Biosciences Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2020
$0
Nov 5, 2020
Q2
2020
Jun 30, 2020
$0
Aug 6, 2020
Q1
2020
Mar 31, 2020
$0
May 7, 2020
Q3
2020
Sep 30, 2019
$0
Nov 5, 2020
Q2
2020
Jun 30, 2019
$0
Aug 6, 2020
Q1
2020
Mar 31, 2019
$0
May 7, 2020
Q3
2019
Sep 30, 2018
$0
Nov 12, 2019
Q2
2019
Jun 30, 2018
$0
Aug 14, 2019
Q1
2019
Mar 31, 2018
$0
May 13, 2019
Q3
2018
Sep 30, 2017
$0
Nov 13, 2018
Q2
2018
Jun 30, 2017
$0
Aug 10, 2018
Q1
2018
Mar 31, 2017
$0
May 10, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
($17.98M)
Nov 3, 2021
Q2
2021
Jun 30, 2021
($18.70M)
Aug 16, 2021
Q1
2021
Mar 31, 2021
($16.90M)
May 14, 2021
Q3
2021
Sep 30, 2020
($21.25M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($18.99M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($26.69M)
May 14, 2021
Q3
2020
Sep 30, 2019
($29.26M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($26.53M)
Aug 6, 2020
Q1
2020
Mar 31, 2019
($29.58M)
May 7, 2020
Q3
2019
Sep 30, 2018
($19.02M)
Nov 12, 2019
Q2
2019
Jun 30, 2018
($17.98M)
Aug 14, 2019
Q1
2019
Mar 31, 2018
($15.88M)
May 13, 2019
Q3
2018
Dec 31, 2017
($53.18M)
Nov 13, 2018
Q1
2018
Dec 31, 2017
($53.18M)
May 10, 2018
Q2
2018
Dec 31, 2017
($53.18M)
Aug 10, 2018
Q3
2018
Sep 30, 2017
($13.51M)
Nov 13, 2018
Q2
2018
Jun 30, 2017
($11.31M)
Aug 10, 2018
Q1
2018
Mar 31, 2017
($12.82M)
May 10, 2018
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($48.06M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($41.69M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($40.05M)
May 15, 2025
Q3
2025
Sep 30, 2024
($35.18M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($27.79M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($26.86M)
May 15, 2025
Q3
2024
Sep 30, 2023
($23.11M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($26.84M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($32.03M)
May 15, 2024
Q3
2023
Sep 30, 2022
($21.13M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($25.38M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($25.37M)
May 11, 2023
Q3
2022
Sep 30, 2021
($18.03M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($18.69M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($16.89M)
Apr 27, 2022
Q3
2021
Sep 30, 2020
($21.23M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($18.97M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($26.86M)
May 14, 2021
Q3
2020
Sep 30, 2019
($29.72M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($26.97M)
Aug 6, 2020